Karius company logo
Karius
Actively Hiring
Changing forever the way infectious diseases are diagnosed51-200 Employees
  • B2B
  • Scale Stage
    Rapidly increasing operations
  • Top Investors
    This company has received a significant amount of investment from top investors
  • Valuation $500M+
    This company has a valuation of $500M or more

Karius careers

Changing forever the way infectious diseases are diagnosed
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive karius® test that helps clinicians make rapid treatment decisions. our laboratory is clia-certified and cap-accredited to perform high-complexity clinical laboratory testing. we provide unique genomic insights by detecting microbial cell-free dna (mcfdna) circulating in the bloodstream from pathogens causing an acute infection. proprietary technology efficiently extracts mcfdna directly from blood and depletes the strong human background signal and environmental contaminants. advanced machine learning algorithms allow analysis of complex genomic data in real-time. proprietary reference genome databases are constantly refined as more data becomes available.

Senior Clinical Data Scientist

Remote only • United States
$133k – $200k
4 weeks ago
Tim Blauwkamp
Avatar for Tim Blauwkamp
President and co-founder @Karius; CEO and co-founder @Moleculo; Worked at @Illumina; Studied at @Weizmann Institute of science and @Stanford University
Total raised

$254M

Funded over

4 rounds

Latest round

Series B (Feb 2020)

10 paid holidays

Unlimited paid time off (pto)

Daily lunch is provided

Company events

Happy hour every friday!

+3 more